But with the anti-infective mAb development pipeline now representing one of the most active areas in mAb development 2, YUMAB is poised to join the race to develop next-generation mAbs to fight ...

Nosopharm is on a mission to discover and develop first-in-class anti-infective therapies to address this critical challenge. Founded in 2009 and headquartered in Lyon, France, the biotechnology ...

The anti-infective drug market is seeing strong growth due to multiple interrelated factors. One key driver is the rising incidence of specific infectious diseases, including healthcare-associated ...

A new Lancet study forecast what may happen over the next 25 years if more isn't done to address antimicrobial resistant ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

A rare parasitic infection known as raccoon roundworm has been confirmed in Los Angeles. The infection, Baylisascaris ...

The following is a summary of “Identification of host endotypes using peripheral blood transcriptomics in a prospective ...

Nigerians with sickle cell disease found relief this weekend as a groundbreaking milestone has been achieved in the fight ...

LUTH and SCFN said the first set of sickle cell patients who were admitted for the programme in August are currently ...

There is no causal link between periodontitis and infective endocarditis (IE), indicating that past clinical practices may have overstated the role of periodontitis in preventing the condition, ...

And most notably, the cause of the disease, the "infective agent" has unusual properties. These unusual properties have prompted much speculation and debate about what the "infective agent" is ...

The Lagos University Teaching Hospital (LUTH), in collaboration with the Sickle Cell Foundation Nigeria (SCFN), has launched a bone marrow ...